{"id":"W2145708032","doi":"10.1023/a:1012208711013","title":"Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin–vindesine","year":2001,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Medicine; Vindesine; Gemcitabine; Internal medicine; Lung cancer; Nausea; Leukopenia; Performance status; Phases of clinical research; Clinical endpoint; Neutropenia; Chemotherapy; Gastroenterology; Surgery; Clinical trial; Oncology; Vincristine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006064213,0.00020801,0.001041597,0.0002179894,0.00004682712,0.000003454772,0.0001013148,0.0001321796,0.0001454801],"category_scores_gemma":[0.0003702007,0.0001784848,0.0001607805,0.0004033845,0.00008375748,0.00006983764,0.00004577943,0.000177853,0.000002376705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002991103,"about_ca_system_score_gemma":0.0005598158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005649505,"about_ca_topic_score_gemma":0.001260751,"domain_scores_codex":[0.9978303,0.0002059073,0.00103473,0.000401813,0.0001979867,0.000329295],"domain_scores_gemma":[0.997449,0.0009705568,0.0005866011,0.0003351076,0.000502347,0.0001564132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7321852,0.04738107,0.1351605,0.0001183521,0.001388267,0.0005742701,0.01136618,0.001329727,0.01091156,0.000005692069,0.0002698478,0.05930936],"study_design_scores_gemma":[0.7609506,0.05334926,0.1722619,0.0002597795,0.00134941,0.000007562588,0.005118663,0.001026797,0.004110827,0.00001029723,0.001330724,0.0002241632],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911168,0.0009444288,0.00004080748,0.0008113976,0.0003395562,0.003980091,0.0000272196,0.00001783942,0.002721833],"genre_scores_gemma":[0.9973809,0.0007478721,0.0005089378,0.0001938835,0.00006815621,0.0003687329,0.00001912533,0.00002492235,0.0006875087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0590852,"threshold_uncertainty_score":0.7278399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0746373964756905,"score_gpt":0.4710071340295249,"score_spread":0.3963697375538344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}